Results 161 to 170 of about 53,142 (237)

Atorvastatin and almonertinib-induced myopathy in a polypharmacy context: a case report. [PDF]

Front Cardiovasc Med
Zhou J, Yu L, Xu H.
europepmc   +1 more source

The Effect of Liraglutide on the Hypolipidemic, Anti-Inflammatory, and Antioxidant Properties of Atorvastatin Mediated via the Nrf2/HO-1 Signaling Pathway: In Vivo and In Silico Validation. [PDF]

Pharmaceutics
Kamar SA, Magdy YM, Abuamara TMM, Sedky AA, Al-Hazani TMI, Alhelf M, Zayed ES, A Yousef T, Al-Dakhil A, Abou-Krisha MM, Almehmadi SJ, Khedr S.   +11 more
europepmc   +1 more source

[Retracted] Atorvastatin increases lipopolysaccharide-induced expression of tumour necrosis factor-α-induced protein 8-like 2 in RAW264.7 cells. [PDF]

Exp Ther Med
Liu MW, Su MX, Zhang W, Wang L, Qian CY.
europepmc   +1 more source

Effect of Atorvastatin Combined With Herb-Partitioned Moxibustion on PON-1 in Patients With Atherosclerotic Cerebral Infarction: A Randomized Controlled Trial. [PDF]

Brain Behav
An W, Hou X, Wei N, Zhou Y, Xie X, Jin Z, Wang L, Li X, Zhuang W, Chen D.   +9 more
europepmc   +1 more source

A Comprehensive, Updated Review of Ezetimibe: Evidence-Based Clinical Use for Atherosclerotic Cardiovascular Disease. [PDF]

Am J Cardiovasc Drugs
Liu HH, Liu ZH, Chen SS, Zhu CG, Li JJ.
europepmc   +1 more source

High-throughput signal detection of hepatotoxic drug-drug interactions in hospitalized elderly patients: an NLP-driven pharmacovigilance study. [PDF]

Ann Med
Ma J, Chen H, Guo C, He G, Yang G.
europepmc   +1 more source

Short-term effect of rosuvastatin versus atorvastatin on the corrected QT interval: a target trial emulation. [PDF]

Eur J Clin Pharmacol
Chen X, Liu Y, Wei W, Xia X, Wu X, Lu X, Hu G, Lu S, Shen Y.   +8 more
europepmc   +1 more source

Early escalation of oral lipid-lowering therapy to achieve LDL-cholesterol targets in patients after myocardial infarction: study protocol for the prospective, open-label HAnnover ChOlesterol Lowering in Acute Coronary Syndrome trial. [PDF]

Front Cardiovasc Med
Schäfer A, Großhennig A, Theis L, Schindler C, Grahl E, Stichtenoth DO, König T, Geller WA, Schmidt HHJG, Bavendiek U, Bauersachs J.   +10 more
europepmc   +1 more source

A hierarchical risk assessment framework for head-to-head comparison of statin safety profiles in Chinese patients. [PDF]

Sci Rep
Tsui L, Wang D, Fan C, Shi C.
europepmc   +1 more source

Efficacy and safety of combination therapy with statin and ezetimibe in patients failing to achieve target LDL levels at cardiology outpatient clinics in Turkey (COM-TR-OLDL): a real-world observational study. [PDF]

Lipids Health Dis
Çolak A, Kumral Z, Öztürk Ö, Ülgen Kunak A, Elmas AN, Bedir Ö, Karaduman M, Babat N, Uyan U, Şentürk N, Tekeli Şengül S, Ömür SE, Koç Ş, Işık MA, Uysal S, Yıldız C, Asiltürk E, Güzel T, Er F, Yazıcı AA, Yeşil E, Bice F, Öztürk C, Yerlikaya MG, Aşkın L, Uçar M, Çakır M, Uluuysal Ö, Özyıldız A, Ozan YD, Kunak T, Öztürk S, Karaca Ö, Kayhan Ö, Mirzayev K, Çelikkale İ, Kırdağ EB, Zoghi M, Ergene AO.   +38 more
europepmc   +1 more source